AORT vs IRMD

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 11, 2026

AORT

48.0
AI Score
VS
AORT Wins

IRMD

31.3
AI Score

Investment Advisor Scores

AORT

48score
Recommendation
HOLD

IRMD

31score
Recommendation
SELL

AI Analyst Insights

Detailed Metrics Comparison

Metric AORT IRMD Winner
Forward P/E 37.8788 41.1523 AORT
PEG Ratio 181.5 4.46 IRMD
Revenue Growth 11.3% 0.3% AORT
Earnings Growth 0.0% -9.3% AORT
Tradestie Score 48.0/100 31.3/100 AORT
Profit Margin -0.7% 26.7% IRMD
Beta 1.00 1.00 Tie
AI Recommendation HOLD SELL AORT

Relative Price Performance (Last 90 Days)

AORT 1M: -13.4% · 3M: +20.4% IRMD 1M: -6.4% · 3M: -15.0%

Current Technical Phase

AORT

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 38

RSI (14): 38.2 · Price: $24.81

IRMD

Markdown
Sell / avoid

Price below a falling SMA50 (slope -3.2%), weak momentum, RSI 28

RSI (14): 27.9 · Price: $81.80

Fundamentals Snapshot

Metric AORT IRMD
Market Cap
Forward P/E 32.9 34.0
Trailing P/E 47.2
Revenue (TTM)
Revenue Growth 0.1% 0.0%
Gross Margin 0.6% 0.8%
Operating Margin 0.1% 0.3%
EPS -0.06 1.77
Dividend Yield 0.01%

Frequently Asked Questions

Based on our detailed analysis, AORT is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.